Brief Pain Inventory


Also found in: Acronyms.

Brief Pain Inventory

A brief, simple, self-administered questionnaire for evaluating pain, which addresses the relevant aspects of pain—history, intensity, timing, location and quality—and the pain’s ability to interfere with the patient’s activities.

Brief Pain Inventory

Neurology A brief, relatively simple, self-administered questionnaire for evaluating pain, which addresses the relevant aspects of pain–history, intensity, timing, location, and quality and the pain's ability to interfere with the Pt's activities. See Pain.
Mentioned in ?
References in periodicals archive ?
Validity of the Brief Pain Inventory for use in documenting the outcomes of patients with noncancer pain.
At 24 hours the groups did not differ for any of the Modified Brief Pain Inventory characteristics (Table 5) or for any health recovery outcomes, including the QoR score (Table 6).
The Brief Pain Inventory Short Form Question12 (BPI SF-12): A self-reporting 11-point numeric rating scale (from 0 to 10) that assessed 'worst pain' in the last 7 days.
Abbreviations: BPI = Brief Pain Inventory, CPCI = Chronic Pain Coping Inventory, CSQ = Coping Strategies Questionnaire, CSQ-1 = CSQ 1-item version, IRB = Institutional Review Board, PCA = principal components analysis, SCI = spinal cord injury, SD = standard deviation, SF-36 = 36-item Short Form Health Survey, SOPA = Survey of Pain Attitudes.
Clinically significant pain, defined as baseline pain score by Brief Pain Inventory (BPI) 4, was present in 44% of patients, with the majority requiring chronic narcotic administration.
The primary outcome was a significant change in pain numerical rating scale (NRS) at one month; secondary outcomes were changes in the Brief Pain Inventory and European Organization for Treatment and Cancer QLC-CIPN-20 (EORTC CIPN-20), over time.
We used a 12-item version of the Brief Pain Inventory (BPI) [24] modified for persons with SCI [2] to measure the degree to which pain has interfered with daily activities during the past week.
Significant differences in the Brief Pain Inventory (BPI) average 24-hour pain score and the Fibromyalgia Impact Questionnaire (FIQ) were seen within 1 week in both the 60 mg/day and 120 mg/day duloxetine groups compared with placebo, with no significant difference between the two dosages.
Ability of the canine brief pain inventory to detect response to treatment in dogs with osteoarthritis.
The patients completed several outcome measures recommended by OMERACT as follows: the Brief Pain Inventory, 30-item Profile of Mood States, Medical Outcomes Sleep Scale, Multidimensional Fatigue Inventory, Multiple Ability Self-Report Questionnaire, Fibromyalgia Impact Questionnaire-Revised and Medical Outcomes Short Form-36.
The primary end point also was measured, substituting the quantitative Brief Pain Inventory for the simple pain intensity scale, Dr.

Full browser ?